https://www.statnews.com/2025/11/11/richard-pazdur-cder-head-win-for-patients-drug-companies/
Richard Pazdur as CDER head is good for patients, pharma | STAT
Nov 12, 2025 - The Food and Drug Administration official has been able to approve new treatments more quickly, on less data, without sacrificing rigor
richard pazdurcderheadgood
https://www.statnews.com/staff/allison-deangelis/
Allison DeAngelis: STAT biotech and pharma reporter
Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital.
stat biotechallisondeangelis
https://www.statnews.com/category/business/
STAT Business: News on hospitals, health care, pharma and more
Exploring the intersection of finance, pharma, and biotech and the impact on health care, the hospital industry and medical research.
business newshealth carestat
https://www.statnews.com/2025/10/24/how-pharmaceutical-companies-won-fda-priority-review-vouchers/
Pharma companies reveal how they won FDA priority review vouchers | STAT
Oct 24, 2025 - The winners include a gene therapy for a rare form of deafness, a plant-based drug for vaping addiction, and ketamine.
pharma companiesfda priority
https://www.statnews.com/category/pharma/
STAT Pharma: The science and business of new drug development
STAT coverage and analysis of top pharmaceutical companies, from clinical trials to FDA approvals, from startups to Big Pharma mergers and acquisitions.
new drugstatpharmascience
https://www.statnews.com/2025/12/23/trump-drug-pricing-deals-medicare-most-favored-nation-demos/
Pharma companies with Trump deals may avoid Medicare price cuts | STAT
pharma companiesprice cutsmay
https://www.statnews.com/2026/01/13/illumina-billion-cell-atlas-ai-drug-development/
Illumina unveils Billion Cell Atlas to help pharma speed drug AI | STAT
Jan 13, 2026 - Illumina is launching a Billion Cell Atlas to help drugmakers validate targets and build AI models of cells, a new growth bet for the firm.
billion cell atlasspeed drug
https://www.statnews.com/2025/12/22/trump-delays-drug-price-transparency-drug-companies-pbm/
PBMs, pharma companies avoid drug price transparency | STAT
Dec 22, 2025 - For more than five years, pharma companies and PBMs have managed to avoid disclosing the actual prices of prescription drugs.
drug price transparencypbms
https://www.statnews.com/2025/10/07/trump-drug-pricing-deals-with-pharma-companies-after-pfizer/
Pharma companies scramble to strike deals with Trump after Pfizer | STAT
Oct 8, 2025 - Pharma companies are hoping to announce deals of their own with President Trump as soon as this week, sources told STAT.
pharma companiesstrike deals
https://www.statnews.com/pharmalot/2026/01/05/biopharma-2026-issues-to-watch-obesity-pills-patent-reform-340b-drugs/
Issues facing pharma and biotech in 2026 | STAT 3 to Watch series
Jan 5, 2026 - Biopharma issues to watch in 2026 include new obesity pills, drug patent protections, and a government drug discount program known as 340B.
issues facingpharmabiotech
https://www.statnews.com/2025/12/01/uk-us-pharma-deal-payments/
U.K. pledges to boost pharma payments, will avoid U.S. tariffs on drugs | STAT
Dec 1, 2025 - The deal marks a win for the Trump administration’s effort to get other countries to pay more for medicines.
u kpledgesboostpharmapayments
https://www.statnews.com/2025/11/18/telehealth-pharma-glp1-partnerships-increase-drug-access-boost-sales/
Telehealth partners fueling GLP-1 drug prescriptions for pharma | STAT
Nov 19, 2025 - Novo Nordisk and telehealth companies are teaming up to route patients to cash-pay GLP-1 drugs, reshaping marketing and access in weight loss care.
pharma stattelehealthpartners